Asthma Drugs Market Expansion at 3.98% CAGR Driven by Innovative...

ha aggiunto una foto Altre informazioni

2026-08-26 07:32:58 -

Asthma Drugs Market Expansion at 3.98% CAGR Driven by Innovative Inhaled Therapies

Asthma drugs in the biologic category—such as omalizumab, mepolizumab, and dupilumab—target specific immune components driving severe, uncontrolled eosinophilic or allergic asthma. Administered via subcutaneous injection, these monoclonal antibodies neutralize specific IgE antibodies, interleukin-5 (IL-5), or interleukin-4/13 pathways. Biologics significantly reduce reliance on...

0 Commenti 0 condivisioni 4 Views 0 Anteprima